Overview Financials News + Filings Key Docs Charts Ownership Insiders |
AXCELIS TECHNOLOGIES INC (ACLS)
|
Add to portfolio |
|
|
Price: |
$76.77
| | Metrics |
OS: |
32.8
|
M
| |
|
|
Market cap: |
$2.52
|
B
| |
|
|
Net cash:
|
$453
|
M
| |
$13.80
|
per share
|
EV:
|
$2.07
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 920.0 | 662.4 | 474.6 | 343.0 | 442.6 | 410.6 | 267.0 | 301.5 |
Revenue growth | 38.9% | 39.6% | 38.4% | -22.5% | 7.8% | 53.8% | -11.4% | 48.5% |
Cost of goods sold | 518.2 | 376.0 | 276.0 | 198.8 | 262.9 | 260.3 | 167.4 | 199.8 |
Gross profit | 401.8 | 286.4 | 198.6 | 144.2 | 179.6 | 150.2 | 99.6 | 101.7 |
Gross margin | 43.7% | 43.2% | 41.8% | 42.0% | 40.6% | 36.6% | 37.3% | 33.7% |
Selling, general and administrative | | | | | | | | |
Sales and marketing | 53.6 | 47.5 | 38.7 | 34.3 | 34.6 | 28.5 | 23.8 | 23.3 |
Research and development | 78.4 | 65.4 | 61.8 | 53.9 | 51.9 | 43.1 | 34.4 | 32.6 |
General and administrative | 57.5 | 46.1 | 40.0 | 31.7 | 33.2 | 30.8 | 24.5 | 25.1 |
EBIT | 212.4 | 127.3 | 58.0 | 24.2 | 60.0 | 47.8 | 16.9 | 20.7 |
EBIT margin | 23.1% | 19.2% | 12.2% | 7.1% | 13.5% | 11.7% | 6.3% | 6.9% |
Pre-tax income | 204.9 | 120.4 | 55.9 | 20.9 | 54.7 | 43.8 | 11.0 | 15.2 |
Income taxes | 21.8 | 21.8 | 5.9 | 3.9 | 8.8 | -83.1 | 0.0 | 0.5 |
Tax rate | 10.6% | 18.1% | 10.6% | 18.6% | 16.1% | | 0.2% | 3.5% |
Net income | 183.1 | 98.7 | 50.0 | 17.0 | 45.9 | 127.0 | 11.0 | 14.7 |
Net margin | 19.9% | 14.9% | 10.5% | 5.0% | 10.4% | 30.9% | 4.1% | 4.9% |
|
Diluted EPS | $5.46 | $2.88 | $1.46 | $0.50 | $1.35 | $3.80 | $0.36 | $0.49 |
Shares outstanding (diluted) | 33.5 | 34.3 | 34.1 | 33.8 | 34.0 | 33.4 | 30.9 | 30.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|